In previous HCC studies, KLF6 has been reported as a tumour suppressor.21 Reduced KLF6 expression was common in both hepatitis B virus (HBV)—and hepatitis C virus (HCV) ‐related HCCs and occurs at critical stages during cancer progression. This evidence concerns the gene KLF6 and hepatocellular carcinoma.